From a new article by David Henderson and Charlie Hooper:
At first, the FDA “grandfathered” older drugs. But in 1997, the FDA decided that some older drugs were actually “new drugs.” Therefore, Forest needed to navigate the FDA’s expensive and difficult new drug approval process. Forest didn’t act quickly enough to follow all the proper procedures and violated the FDA’s deadlines
…
In threatening not to buy drugs from Forest Laboratories unless it fires its CEO, the feds are taking a major step toward taking over companies.
What was Forest’s other sin? Promoting off-label uses. Who else does that? Almost every doctor in America–and the federal government. Here’s another excerpt:
And here’s the irony. The U.S. government itself, through the Medicare program, for example, regularly pays for drugs prescribed off-label. Moreover, the government itself sometimes funds studies for off-label uses. The National Institute of Health National Eye Institute, for example, funded a clinical trial of Genentech’s Avastin, already approved for cancer, for use on wet age-related macular degeneration. And the results, which came out last week, are promising. If off-label usage threatens public health, then Medicare and the NIH never got the memo …
Have a lovely evening. I am sure this is exactly what “necessary and proper” means.
973804 646866Hello. excellent job. I did not anticipate this. This really is a excellent story. Thanks! You produced certain fine points there. I did a search on the subject matter and discovered the majority of folks will have the same opinion with your blog. 734734
866657 609981Some truly good and useful info on this web site, likewise I conceive the style holds excellent functions. 12566
85726 145528Keep up the fantastic piece of function, I read couple of posts on this internet website and I believe that your weblog is actually fascinating and holds bands of great details. 531538
63280 472632Hey there! Good stuff, do keep us posted when you finally post something like that! 228430